New Issue: Raptor Pharmaceuticals seals $2.39 million private placement of units

By Devika Patel

Knoxville, Tenn., Aug. 25 - Raptor Pharmaceuticals Corp. said it completed a $2.39 million private placement of units. The deal priced for $2.24 million on June 23.

The company sold 7,456,250 units of one common share and one half-share warrant at $0.32 per unit.

Each whole, two-year warrant will be exercisable at $0.60 in the first year and at $0.75 thereafter.

Raptor is a Novato, Calif., biotechnology company that bioengineers novel drugs and drug-targeting platforms derived from the human receptor-associated protein and related proteins.

Issuer:	Raptor Pharmaceuticals Corp.
Issue:	Units of one common share and one half-share warrant
Amount:	$2,386,000
Units:	7,456,250
Price:	$0.32
Warrants:	One half-share warrant per unit
Warrant expiration:	Two years
Warrant strike price:	$0.60 in the first year, $0.75 thereafter
Pricing date:	June 23
Settlement date:	Aug. 25
Stock symbol:	OTCBB: RPTP
Stock price:	$0.38 at close June 22
Market capitalization:	$22.3 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.